Average Co-Inventor Count = 5.75
ph-index = 7
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Bristol-Myers Squibb Compnay (16 from 3,687 patents)
2. Bristol-Myers Squibb Pharma Company (234 patents)
16 patents:
1. 12365667 - Sulfone pyridine alkyl amide-substituted heteroaryl compounds
2. 12240840 - Amide-substituted heterocyclic compounds for the treatment of conditions related to the modulation of IL-12, IL-23 and/or IFN-alpha
3. 11884650 - Substituted heterocyclic compounds
4. 11866414 - Substituted heterocyclic compounds
5. 11787779 - Sulfone pyridine alkyl amide-substituted heteroaryl compounds
6. 11021475 - Amide-substituted heterocyclic compounds useful as modulators of IL-12, IL-23 and/or IFN alpha responses
7. 11021462 - Sulfone pyridine alkyl amide-substituted heteroaryl compounds
8. RE47929 - Amide-substituted heterocyclic compounds useful as modulators of IL-12, IL-23 and/or IFNα responses
9. 10479793 - Imidazopyridazine compounds useful as modulators of IL-12, IL-23 and/or IFN alpha responses
10. 10273237 - Imidazopyridazine compounds useful as modulators of IL-12, IL-23 and/or IFN-α responses
11. 10000480 - Amide-substituted heterocyclic compounds useful as modulators of IL-12, IL-23 and/or IFN alpha responses
12. 9987266 - Alkyl-amide-substituted pyridyl compounds useful as modulators of IL-12, IL-23 and/or IFNα responses
13. 9663467 - Alkyl-amide-substituted pyridyl compounds useful as modulators of IL-12, IL-23 and/or IFNα responses
14. 9540333 - Alkyl amide-substituted pyrimidine compounds useful in the modulation of IL-12, IL-23 and/or IFNα
15. 9505748 - Amide-substituted heterocyclic compounds useful as modulators of IL-12, IL-23 and/or IFNα responses